BlueStar® Genomic Health Care Index

The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.

Key Features

Size and Liquidity RequirementsFloat-adjusted market capitalization of at least 300 mln USD. Six-month average-daily-value-traded of at least 200000 USD.
UniverseCompanies developing or producing gene-based healthcare technologies and therapies.
DiversificationCompanies are liquidity weighted.
ReviewSemi-annual in June and December.
IndexLast CloseOpenLastChangeChange (1Y)Range (1Y)
167.23 167.23 --67.39%98.32 - 380.65
167.64 167.64 --67.66%98.41 - 381.50
Symbol IndexName
BDNAPR BlueStar® Genomic Health Care Price Index
BDNANTR BlueStar® Genomic Health Care Total Return Net Index